DLGAP5 Drives Lung Adenocarcinoma Cell Growth by Promoting Autophagy Activity
Canadian Respiratory Journal · 2026-01 · 2026 (1)
DOI: 10.1155/carj/2731987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Respiratory Journal, online erschienen am 08.06.2026. Verfasst von Shuying You und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The Second People's Hospital of Hunan Province/Brain Hospital of Hunan Province, Changsha, China. Hauptthemen laut MEDLINE: Autophagy, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain Hospital of Hunan Province, Second People's Hospital of Hunan Province, Hunan Provincial Health Commission Project.
Abstract (Originalsprache)
Background
Autophagy is reported to participate in tumorigenesis and plays a vital role in tumor cell survival. Here, we aimed to elucidate the regulatory mechanism between discs large homolog‐associated protein 5 (DLGAP5) and autophagy in lung adenocarcinoma (LUAD) development.
Methods
RT‐qPCR and western blot methods were utilized to assess DLGAP5 expression. Cell proliferation and apoptosis abilities were monitored utilizing Cell Counting Kit 8 (CCK‐8), EdU, and flow cytometry assays. Autophagy‐related proteins were quantified using western blot and immunofluorescence analysis. A xenograft tumor model was established to measure tumor growth.
Results
DLGAP5 was significantly overexpressed in LUAD cell lines compared to 16HBE cells, especially in PC‐9 and A549 cells. Functional assays highlighted that loss of function of DLGAP5 repressed cell proliferation and triggered apoptosis both in vitro and in vivo, while DLGAP5 overexpression had the opposite effect. After DLGAP5 blockage, the autophagy‐related LC3II/I and Beclin1 expressions declined, while p62 expression increased. Moreover, the increased proliferation and autophagy activity and suppressed apoptosis mediated by DLGAP5 overexpression were greatly restrained after 3‐MA (an autophagy‐specific inhibitor).
Conclusion
To sum up, DLGAP5 could contribute to proliferation and impede apoptosis of LUAD cells by activating autophagy activity, suggesting that targeting DLGAP5 might be a promising approach for LUAD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, The Second People's Hospital of Hunan Province/Brain Hospital of Hunan Province, Changsha, China.
- Department of Respiratory Medicine, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University, Changsha, China, hunnu.edu.cn.
ORCID-Profile: Lile Wang
Förderung
- Brain Hospital of Hunan Province
- Second People's Hospital of Hunan Province
- Hunan Provincial Health Commission Project
- Hunan Provincial Clinical medical technology innovation guide project
Zitieren
APA
You, S., Zeng, X., Li, N., & Wang, L. (2026). DLGAP5 Drives Lung Adenocarcinoma Cell Growth by Promoting Autophagy Activity. Canadian Respiratory Journal, 2026(1). https://doi.org/10.1155/carj/2731987
Vancouver
You S, Zeng X, Li N, Wang L. DLGAP5 Drives Lung Adenocarcinoma Cell Growth by Promoting Autophagy Activity. Canadian Respiratory Journal. 2026;2026(1). doi:10.1155/carj/2731987
BibTeX
@article{You2026,
author = {You, Shuying and Zeng, Xiangbo and Li, Na and Wang, Lile},
title = {DLGAP5 Drives Lung Adenocarcinoma Cell Growth by Promoting Autophagy Activity},
journal = {Canadian Respiratory Journal},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/carj/2731987}
}
EUVIMED